These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 14529360

  • 1. Poly(ADP-ribosyl)ation enzyme-1 as a target for neuroprotection in acute central nervous system injury.
    Skaper SD.
    Curr Drug Targets CNS Neurol Disord; 2003 Oct; 2(5):279-91. PubMed ID: 14529360
    [Abstract] [Full Text] [Related]

  • 2. Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection.
    Skaper SD.
    Ann N Y Acad Sci; 2003 May; 993():217-28; discussion 287-8. PubMed ID: 12853316
    [Abstract] [Full Text] [Related]

  • 3. Blockade of PARP activity attenuates poly(ADP-ribosyl)ation but offers only partial neuroprotection against NMDA-induced cell death in the rat retina.
    Goebel DJ, Winkler BS.
    J Neurochem; 2006 Sep; 98(6):1732-45. PubMed ID: 16903875
    [Abstract] [Full Text] [Related]

  • 4. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ, Bourgeois M, Harbison RD.
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [Abstract] [Full Text] [Related]

  • 5. Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway in neural stem/progenitor cells.
    Okuda A, Kurokawa S, Takehashi M, Maeda A, Fukuda K, Kubo Y, Nogusa H, Takatani-Nakase T, Okuda S, Ueda K, Tanaka S.
    BMC Neurosci; 2017 Jan 17; 18(1):14. PubMed ID: 28095779
    [Abstract] [Full Text] [Related]

  • 6. Expression of poly(ADP-ribose) polymerase and distribution of poly(ADP-ribosyl)ation in glioblastoma and in a glioma multicellular tumour spheroid model.
    Wharton SB, McNelis U, Bell HS, Whittle IR.
    Neuropathol Appl Neurobiol; 2000 Dec 17; 26(6):528-35. PubMed ID: 11123719
    [Abstract] [Full Text] [Related]

  • 7. Poly(ADP-ribose) polymerase: killer or conspirator? The 'suicide hypothesis' revisited.
    Chiarugi A.
    Trends Pharmacol Sci; 2002 Mar 17; 23(3):122-9. PubMed ID: 11879679
    [Abstract] [Full Text] [Related]

  • 8. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
    Virág L.
    Curr Vasc Pharmacol; 2005 Jul 17; 3(3):209-14. PubMed ID: 16026317
    [Abstract] [Full Text] [Related]

  • 9. Poly(ADP-ribosyl)ation and stroke.
    Chiarugi A.
    Pharmacol Res; 2005 Jul 17; 52(1):15-24. PubMed ID: 15911330
    [Abstract] [Full Text] [Related]

  • 10. Regulation of p53 sequence-specific DNA-binding by covalent poly(ADP-ribosyl)ation.
    Mendoza-Alvarez H, Alvarez-Gonzalez R.
    J Biol Chem; 2001 Sep 28; 276(39):36425-30. PubMed ID: 11477085
    [Abstract] [Full Text] [Related]

  • 11. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
    Kuchmerovska T, Shymanskyy I, Donchenko G, Kuchmerovskyy M, Pakirbaieva L, Klimenko A.
    J Diabetes Complications; 2004 Sep 28; 18(4):198-204. PubMed ID: 15207836
    [Abstract] [Full Text] [Related]

  • 12. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.
    Dantzer F, Amé JC, Schreiber V, Nakamura J, Ménissier-de Murcia J, de Murcia G.
    Methods Enzymol; 2006 Sep 28; 409():493-510. PubMed ID: 16793420
    [Abstract] [Full Text] [Related]

  • 13. Poly(ADP-ribosyl)ation of p53 in vitro and in vivo modulates binding to its DNA consensus sequence.
    Simbulan-Rosenthal CM, Rosenthal DS, Luo RB, Samara R, Jung M, Dritschilo A, Spoonde A, Smulson ME.
    Neoplasia; 2001 Sep 28; 3(3):179-88. PubMed ID: 11494111
    [Abstract] [Full Text] [Related]

  • 14. The sequence-specific DNA binding of NF-kappa B is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1.
    Chang WJ, Alvarez-Gonzalez R.
    J Biol Chem; 2001 Dec 14; 276(50):47664-70. PubMed ID: 11577079
    [Abstract] [Full Text] [Related]

  • 15. Poly(ADP-ribosyl)ation regulation of life and death in the nervous system.
    Koh DW, Dawson TM, Dawson VL.
    Cell Mol Life Sci; 2005 Apr 14; 62(7-8):760-8. PubMed ID: 15868401
    [Abstract] [Full Text] [Related]

  • 16. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.
    D'Amours D, Desnoyers S, D'Silva I, Poirier GG.
    Biochem J; 1999 Sep 01; 342 ( Pt 2)(Pt 2):249-68. PubMed ID: 10455009
    [Abstract] [Full Text] [Related]

  • 17. Poly(ADP-ribose) polymerase inhibitors.
    Southan GJ, Szabó C.
    Curr Med Chem; 2003 Feb 01; 10(4):321-40. PubMed ID: 12570705
    [Abstract] [Full Text] [Related]

  • 18. The role of poly(ADP-ribose) polymerase-1 in CNS disease.
    Kauppinen TM, Swanson RA.
    Neuroscience; 2007 Apr 14; 145(4):1267-72. PubMed ID: 17084037
    [Abstract] [Full Text] [Related]

  • 19. Functional interactions of p53 with poly(ADP-ribose) polymerase (PARP) during apoptosis following DNA damage: covalent poly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalent binding of p53 to the M(r) 85,000 proteolytic fragment.
    Kumari SR, Mendoza-Alvarez H, Alvarez-Gonzalez R.
    Cancer Res; 1998 Nov 15; 58(22):5075-8. PubMed ID: 9823314
    [Abstract] [Full Text] [Related]

  • 20. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain.
    Tokime T, Nozaki K, Sugino T, Kikuchi H, Hashimoto N, Ueda K.
    J Cereb Blood Flow Metab; 1998 Sep 15; 18(9):991-7. PubMed ID: 9740102
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.